Table 2.
Differentially expressed proteins between T. gondii-infected and non-infected mouse brain tissues
| Spot No. | Accession No. | Protein name | Score | Expect | Queries matched | Sequence Coverage | Nominal mass | Calculated pI value | Matched peptides | Fold change (Infected/non-infected)A | Functional categoriesB |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Day 7, down-regulated proteins | |||||||||||
| 1 |
IPI00230394 |
Lamin-B1 |
288 |
9.00E-25 |
27 |
36 |
66973 |
5.11 |
ASAPATPLSPTR;LQEKEELR;SLETENSALQLQVTEREEVR;ALYETELADARR;LREYEAALNSK;VDLENRCQSLTEDLEFRKNMYEEEINETRR;LVEVDSGR;LAQALHEMREQHDAQVRLYKEELEQTYHAK;LALDMEISAYR;LKNTSEQDQPMGGWEMIR;NQNSWGTGEDVK;NSQGEEVAQR;TTIPEEEEEEEEEPIGVAVEEERFHQQGAPR |
−2.91 |
Structural molecule activity |
| 2 |
IPI00944143 |
Serpin B6 isoform a |
218 |
9.00E-18 |
9 |
25 |
45201 |
5.99 |
SRPGCCAGPRGYR;NVFLSPMSISSALAMVFMGAK;TGTQYLLR;FYEAELEELDFQGATEESR;FIEWTR;LGMTDAFGGR;AFVEVNEEGTEAAAATAGMMTVR |
−1.68 |
Enzyme regulator activity and metabolic process |
| 3 |
IPI00110721 |
Isoform 1 of Glyoxalase domain-containing protein 4 |
508 |
9.00E-47 |
12 |
41 |
33581 |
5.28 |
FQTVHFFRDVLGMQVLRHEEFEEGCK;LGNDFMGITLASSQAVSNAR;VAEGIFETEAPGGYKFYLQDR;IYEQDEEKQR;LELQGIQGAVDHAAAFGR;ELPDLEDLMKR;LLDDAMEADKSDEWFATR |
−1.51 |
Cell part and organelle |
| 4 |
IPI00113660 |
Proteasome activator complex subunit 3 |
471 |
4.50E-43 |
9 |
42 |
29602 |
5.69 |
ITSEAEDLVANFFPK;RLDECEEAFQGTK;SNQQLVDIIEKVKPEIR;IEDGNNFGVSIQEETVAELRTVESEAASYLDQISRYYITR;YPHVEDYRRTVTEIDEKEYISLR |
−1.70 |
Enzyme regulator activity |
| 5 |
IPI00130344 |
Chloride intracellular channel protein 1 |
202 |
3.60E-16 |
6 |
39 |
27338 |
5.09 |
IGNCPFSQR;YPKLAALNPESNTSGLDIFAK;VLDNYLTSPLPEEVDETSAEDEGISQR;GFTIPEAFR;YLSNAYAREEFASTCPDDEEIELAYEQVAR |
−1.89 |
Transporter activity |
| 6 |
IPI00121851 |
Prefoldin subunit 3 |
133 |
2.90E-09 |
4 |
15 |
22592 |
6 |
FLLADNLYCK;NLDSLEEDLDFLR;VYNWDVKR |
−1.51 |
Metabolic process |
| 7 |
IPI00315794 |
Cytochrome b5 |
212 |
3.60E-17 |
6 |
54 |
16365 |
4.79 |
VEGSEPSVTYYR;NSAEETWMVIHGRVYDITRFLSEHPGGEEVLLEQAGADATESFEDVGHSPDAR;QYYIGDVHPSDLKPK |
−1.70 |
Binding and enzyme activator activity |
| 8 |
IPI00124501 |
Galectin-related protein A |
257 |
1.10E-21 |
8 |
57 |
19172 |
5.12 |
LDDGHLNNSLGSPVQADVYFPRLIVPFCGHIK;AVFTDR;NSCISGERGEEQSAIPYFPFIPDQPFRVEILCEHPR;VFVDGHQLFDFYHRIQTLSAIDTIK |
−1.74 |
Binding |
| 9 |
IPI00308984 |
Eukaryotic translation initiation factor 1A |
248 |
9.00E-21 |
3 |
28 |
16564 |
5.07 |
ELVFKEDGQEYAQVIK;LEAMCFDGVKR;VWINTSDIILVGLR |
−1.67 |
Binding |
|
Day 7, up-regulated proteins | |||||||||||
| 10 |
IPI00131830 |
Serine protease inhibitor A3K |
470 |
5.70E-43 |
9 |
28 |
47021 |
5.05 |
DLQILAEFHEK;ALYQTEAFTADFQQPTEAK;ELISELDER;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;FSIASNYR;AVLDVAETGTEAAAATGVIGGIR |
2.55 |
Enzyme regulator activity |
| 11 |
IPI00131830 |
Serine protease inhibitor A3K |
511 |
4.50E-47 |
12 |
35 |
47021 |
5.05 |
DLQILAEFHEK;ALYQTEAFTADFQQPTEAK;ELISELDER;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;FSIASNYRLEEDVLPEMGIKEVFTEQADLSGITETK;AVLDVAETGTEAAAATGVIGGIR |
3.15 |
Enzyme regulator activity |
| 12 |
IPI00131830 |
Serine protease inhibitor A3K |
463 |
2.90E-42 |
10 |
28 |
47021 |
5.05 |
DLQILAEFHEK;ALYQTEAFTADFQQPTEAK;ELISELDER;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;FSIASNYR;AVLDVAETGTEAAAATGVIGGIR |
6.30 |
Enzyme regulator activity |
| 13 |
IPI00131830 |
Serine protease inhibitor A3K |
564 |
2.30E-52 |
14 |
35 |
47021 |
5.05 |
DLQILAEFHEK;ALYQTEAFTADFQQPTEAK;ELISELDER;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;FSIASNYRLEEDVLPEMGIKEVFTEQADLSGITETKK;AVLDVAETGTEAAAATGVIGGIR |
4.02 |
Enzyme regulator activity |
| 14 |
IPI00131830 |
Serine protease inhibitor A3K |
596 |
1.40E-55 |
12 |
35 |
47021 |
5.05 |
DLQILAEFHEK;ALYQTEAFTADFQQPTEAK;ELISELDER;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;FSIASNYRLEEDVLPEMGIKEVFTEQADLSGITETK;AVLDVAETGTEAAAATGVIGGIR |
5.80 |
Enzyme regulator activity |
| 15 |
IPI00310972 |
GTP-GDP dissociation stimulator 1 isoform b |
490 |
5.70E-45 |
18 |
27 |
61381 |
5.28 |
NEFMR;DQEVLLQTGR;EQFASTNIAEELVK;QIEHDKREMIFEVLAPLAENDAIK;LMDLLDRHVEDGNVTVQHAALSALR;SEMPPVQFK;MLIDAQAEAAEQLGK;LVEWCEAKDHAGVMGESNR;DLASAQLVQILHRLLADER;SVAQQASLTEQR |
8.32 |
Cell part and organelle part |
|
Day 14, down-regulated proteins | |||||||||||
| 16 |
IPI00131871 |
COP9 signalosome complex subunit 4 |
449 |
7.20E-41 |
18 |
50 |
46541 |
5.57 |
QLLTDFCTHLPNLPDSTAK;VISFEEQVASIRQHLASIYEKEEDWRNAAQVLVGIPLETGQKQYNVDYKLETYLK;LYLEDDDPVQAEAYINRASLLQNESTNEQLQIHYK;KFIEAAQR;TIVHESERLEALKHALHCTILASAGQQR;MLATLFKDERCQQLAAYGILEK;ATTADGSSILDR;IASQMITEGRMNGFIDQIDGIVHFETR |
−2.50 |
Metabolic process |
| 17 |
IPI00338039 |
Tubulin beta-2A chain |
591 |
4.50E-55 |
22 |
42 |
50274 |
4.78 |
MREIVHIQAGQCGNQIGAKFWEVISDEHGIDPTGSYHGDSDLQLERINVYYNEAAGNK;AILVDLEPGTMDSVR;GHYTEGAELVDSVLDVVRK;IREEYPDRIMNTFSVMPSPK;FPGQLNADLRKLAVNMVPFPRLHFFMPGFAPLTSRGSQQYRALTVPELTQQMFDSKNMMAACDPR;ISEQFTAMFRR |
−1.90 |
Structural molecule activity |
| 18 |
IPI00113660 |
Proteasome activator complex subunit 3 |
450 |
5.70E-41 |
11 |
43 |
29602 |
5.69 |
ERITSEAEDLVANFFPK;RLDECEEAFQGTK;SNQQLVDIIEKVKPEIR;IEDGNNFGVSIQEETVAELRTVESEAASYLDQISRYYITR;YPHVEDYRRTVTEIDEKEYISLR |
−2.04 |
Enzyme regulator activity |
| 19 |
IPI00407019 |
Tetratricopeptide repeat protein 19 |
348 |
9.00E-31 |
12 |
23 |
41550 |
5.87 |
LSIMKDEPEAAELILHDALRLAYESDNRK;GQLENAEQLFK;QLSQAQR;ALQICQEIQGER;EIYQEALKR;RDEVSVQHIREELAELSR |
−1.99 |
Cell part, organelle and organelle part |
| 20 |
IPI00133440 |
Prohibitin |
688 |
9.00E-65 |
14 |
42 |
29859 |
5.57 |
AVIFDRFR;DLQNVNITLRILFRPVASQLPRIYTSIGEDYDERVLPSITTEILK;FDAGELITQR;QVSDDLTER;QVAQQEAER;AAELIANSLATAGDGLIELRKLEAAEDIAYQLSR |
−4.73 |
Metabolic process |
| 21 |
IPI00313962 |
Ubiquitin carboxyl-terminal hydrolase isozyme L1 |
340 |
5.70E-30 |
8 |
39 |
25165 |
5.14 |
LGVAGQWR;QIEELKGQEVSPK;QFLSETEKLSPEDR;CFEKNEAIQAAHDSVAQEGQCR;MPFPVNHGASSEDSLLQDAAK;EFTEREQGEVR |
−1.68 |
Cell proliferation |
| 22 |
IPI00322312 |
Rho GDP-dissociation inhibitor 1 |
536 |
1.40E-49 |
12 |
49 |
23450 |
5.12 |
SIQEIQELDKDDESLR;YKEALLGRVAVSADPNVPNVIVTR;EGVEYR;YIQHTYR;IDKTDYMVGSYGPRAEEYEFLTPMEEAPK;FTDDDKTDHLSWEWNLTIK |
−4.10 |
Enzyme regulator activity |
| 23 |
IPI00845712 |
Isoform 1 of UPF0424 protein C1orf128 homolog |
540 |
5.70E-50 |
17 |
73 |
24405 |
5.48 |
CAAEREEPPEQRGLAYGLYLR;LQCLNESR;GVFKPWEER;FVESDADEELLFNIPFTGNVKLKGVIIMGEDDDSHPSEMR;NIPQMSFDDTEREPEQTFSLNRDITGELEYATK;IFYIGLRGEWTELRRHEVTICNYEASANPADHRVHQVTPQTHFIS; |
−2.40 |
Cell part, organelle and organelle part |
| 24 |
IPI00221826 |
Isoform Short of Splicing factor, arginine/serine-rich 3 |
226 |
1.40E-18 |
7 |
41 |
14422 |
10.12 |
DSCPLDCK;AFGYYGPLRSVWVARNPPGFAFVEFEDPR;NRGPPPSWGR;DDYRR |
−1000000 |
Metabolic process |
|
Day 14, up-regulated proteins | |||||||||||
| 25 |
IPI00123613 |
Protein kinase C and casein kinase substrate in neurons protein 1 |
382 |
3.60E-34 |
15 |
40 |
50886 |
5.15 |
LCNDLMSCVQER;AYAQQLTDWAKR;AWGAMMTEADKVSELHQEVK;AYHLACKEER;TTPQYMEGMEQVFEQCQQFEEKR;HLNLAENSSYMHVYRELEQAIRGADAQEDLR;KAEGATLSNATGAVESTSQAGDR;ALYDYDGQEQDELSFK;LGEEDEQGWCRGRLDSGQLGLYPANYVEAI |
4.65 |
Catalytic activity and binding |
| 26 |
IPI00110265 |
Isoform 1 of NAD-dependent deacetylase sirtuin-2 |
255 |
1.80E-21 |
11 |
35 |
43856 |
5.23 |
NLFTQTLGLGSQK;LLDELTLEGVTRYMQSER;VICLVGAGISTSAGIPDFR;HPEPFFALAK;CYTQNIDTLER;IFSEATPRCEQCQSVVKPDIVFFGENLPSR;APLATPR;ELEDLVRREHANIDAQSGSQAPNPSTTISPGK |
1.57 |
Catalytic activity and binding |
| 27 |
IPI00649438 |
Novel protein similar to splicing factor, arginine/serine-rich 3 |
80 |
0.00061 |
3 |
19 |
19404 |
11.41 |
NPPGFAFVEFEDPRDAADAVR;NRGLPPSWGR |
1.65 |
Metabolic process |
|
Day 21, down-regulated proteins | |||||||||||
| 28 |
IPI00133522 |
Protein disulfide-isomerase |
408 |
9.00E-37 |
17 |
37 |
57507 |
4.79 |
SNFEEALAAHK;ALAPEYAKR;LKAEGSEIR;VDATEESDLAQQYGVR;YQLDKDGVVLFKKFDEGRNNFEGEITK;HNQLPLVIEFTEQTAPK;ILFIFIDSDHTDNQR;KEECPAVR;YKPESDELTAEKITEFCHR;IKPHLMSQEVPEDWDKQPVKVLVGANFEEVAFDEKK;LGETYKDHENIIIAK;FFPASADR |
−1.52 |
Metabolic process |
| 29 |
IPI00756786 |
SH3-domain GRB2-like endophilin B2 |
258 |
9.00E-22 |
11 |
26 |
45165 |
5.44 |
KLASDAGIFFTR;FGQAEKTELDAHFENLLAR;NWTER;QTEVLLQPNPSAR;ATCEGDTVPDFQETRPR;VAQTEFDRQAEVTRLLLEGISSTHVNHLR;SQTTYYAQCYR |
−1.50 |
Cellular process |
| 30 |
IPI00111556 |
Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform |
239 |
7.20E-20 |
10 |
34 |
36123 |
5.21 |
SPDTNYLFMGDYVDR;QITQVYGFYDECLRKYGNANVWK;LQEVPHEGPMCDLLWSDPDDRGGWGISPR;AHQLVMEGYNWCHDRNVVTIFSAPNYCYR;YSFLQFDPAPR |
−2.10 |
Metabolic process |
| 31 |
IPI00798544 |
Isoform 2 of Enolase-phosphatase E1 |
384 |
2.30E-34 |
11 |
24 |
25457 |
4.92 |
QLQGHMWK;MKAEFFADVVPAVRRWREAGMKVYIYSSGSVEAQK;GHKVDSESYRK |
−3.54 |
Metabolic process |
| 32 |
IPI00230145 |
Ferritin heavy chain |
408 |
9.00E-37 |
11 |
65 |
21224 |
5.53 |
QNYHQDAEAAINR;YFLHQSHEEREHAEK;KPDRDDWESGLNAMECALHLEKSVNQSLLELHKLATDKNDPHLCDFIETYYLSEQVK;ELGDHVTNLRKMGAPEAGMAEYLFDKHTLGHGDES |
−1.56 |
Immune system process |
|
Day 21, up-regulated proteins | |||||||||||
| 33 |
IPI00403810 |
Tubulin alpha-1C chain |
174 |
2.30E-13 |
5 |
16 |
50562 |
4.96 |
AVFVDLEPTVIDEVR;EIIDLVLDR;NLDIERPTYTNLNR;FDGALNVDLTEFQTNLVPYPRIHFPLATYAPVISAEK |
1.56 |
Structural molecule activity |
| 34 |
IPI00221540 |
Erlin-2 |
339 |
7.20E-30 |
8 |
17 |
38077 |
5.37 |
SVQTTLQTDEVK;VTKPNIPEAIRR;VAQVAEITYGQK;KISEIEDAAFLAR;AKADAECYTALK |
1.85 |
Metabolic process |
| 35 |
IPI00230192 |
Isoform Alpha-1 of Guanine nucleotide-binding protein G(o) subunit alpha |
170 |
5.70E-13 |
5 |
16 |
40629 |
5.34 |
AMDTLGVEYGDKER;LWGDSGIQECFNR;YYLDSLDRIGAGDYQPTEQDILR;LFDVGGQR |
1.54 |
Signal transducer activity |
| 36 |
IPI00653664 |
Isoform 1 of Enolase-phosphatase E1 |
365 |
1.80E-32 |
11 |
27 |
28696 |
4.79 |
EYLQTHWEEEECQQDVSLLR;QLQGHMWK;MKAEFFADVVPAVRRWREAGMKVYIYSSGSVEAQK;VDSESYRK |
1.96 |
Metabolic process |
| 37 |
IPI00130280 |
ATP synthase subunit alpha |
376 |
1.40E-33 |
11 |
18 |
59830 |
9.22 |
TGTAEMSSILEERILGADTSVDLEETGRVLSIGDGIAR;NVQAEEMVEFSSGLK;TGAIVDVPVGEELLGR;APGIIPRISVREPMQTGIKAVDSLVPIGR;ELI IGDR |
2.43 |
Transporter activity and developmental process |
| 38 |
IPI00129161 |
Somatotropin |
201 |
4.50E-16 |
14 |
45 |
24986 |
5.97 |
AQHLHQLAADTYKEFERAYIPEGQR;EEAQQRTDMELLR;IFTNSLMFGTSDR;LKDLEEGIQALMQELEDGSPR;QTYDKFDANMR;AETYLR;RFVESSCAF |
19.73 |
Cell proliferation |
|
Spots 39–46 were down-regulated on both day 14 and day 21 | |||||||||||
| 39 |
IPI00119113 |
V-type proton ATPase subunit B |
641 |
4.50E-60 |
34 |
64 |
56857 |
5.57 |
MALRAMRGIVNGAAPELPVPTGGPMAGAR;NYLSQPR;YAEIVHLTLPDGTKR;AVVQVFEGTSGIDAKKTSCEFTGDILRTPVSEDMLGR;GPVVLAEDFLDIMGQPINPQCRIYPEEMIQTGISAIDGMNSIAR;IPIFSAAGLPHNEIAAQICR;SKDVVDYSEENFAIVFAAMGVNMETAR;LALTTAEFLAYQCEKHVLVILTDMSSYAEALR;RGFPGYMYTDLATIYER;QIYPPINVLPSLSRLMKSAIGEGMTR;DHADVSNQLYACYAIGK;AVVGEEALTSDDLLYLEFLQK;NFITQGPYENRTVYETLDIGWQLLR;RIPQSTLSEFYPR |
−2.11 |
Transporter activity |
| 40 |
IPI00759870 |
Isoform 4 of Heterogeneous nuclear ribonucleoproteins C1/C2 |
201 |
4.50E-16 |
3 |
9 |
32261 |
4.95 |
GFAFVQYVNER;MYSYPARVPPPPPIAR |
−1.52 |
Metabolic process |
| 41 |
IPI00115117 |
Stomatin-like protein 2 |
231 |
4.50E-19 |
12 |
32 |
38475 |
8.95 |
NTVILFVPQQEAWVVER;ILEPGLNVLIPVLDR;ASYGVEDPEYAVTQLAQTTMR;YEIKDIHVPPRVKESMQMQVEAER;ATVLESEGTR;APVPGAQNSSQSRRDVQATDTSIEELGR |
−2.33 |
Organelle and organelle part |
| 42 |
IPI00830393 |
Putative uncharacterized protein Cops6 |
209 |
7.20E-17 |
8 |
31 |
33855 |
5.65 |
SQEGRPMQVIGALIGK;NIEVMNSFELLSHTVEEK;QVCEIIESPLFLK;IGVDHVAR;LILEYVKASEAGEVPFNHEILR;TCNTMNQFVNKFNVLYDR |
−2.91 |
Cellular process and metabolic process |
| 43 |
IPI00311515 |
Beta-soluble NSF attachment protein |
415 |
1.80E-37 |
20 |
69 |
33878 |
5.32 |
EAVQLMAEAEKR;ASHSFLRGLFGGNTRIEEACEMYTR;NWSAAGNAFCQAAK;HDSATSFVDAGNAYK;HHITIAEIYETELVDIEKAIAHYEQSADYYKGEESNSSANK;VAAYAAQLEQYQKAIEIYEQVGANTMDNPLLK;AALCHFIVDELNAKLALEKYEEMFPAFTDSRLLEAHEEQNSEAYTEAVKEFDSISRLDQWLTTMLLR; |
−1.67 |
Cellular process |
| 44 |
IPI00322312 |
Rho GDP-dissociation inhibitor 1 |
396 |
1.40E-35 |
9 |
42 |
23450 |
5.12 |
SIQEIQELDKDDESLR;YKEALLGRVAVSADPNVPNVIVTR;EGVEYR;YIQHTYR;IDKTDYMVGSYGPR;FTDDDKTDHLSWEWNLTIK |
−1000000 |
Enzyme regulator activity |
| 45 |
IPI00133853 |
UPF0687 protein C20orf27 homolog |
268 |
9.00E-23 |
8 |
50 |
19692 |
6.19 |
FAAGHDAEGSQSHVHFDEK;YEITFTLPPVR;ETPVHSLHLKLLSVTPTSEGYSIK;EGVLKEEMLLACEGDIGTCVR;HHGTPMLLDGVK |
−1.70 |
Cell part and organelle part |
| 46 |
IPI00315504 |
ADP-ribosylation factor-like protein 2 |
75 |
0.0016 |
2 |
8 |
21022 |
5.67 |
ELQSLLVEER;SHHWR |
−1.66 |
Binding |
|
Spots 47–56 were up-regulated on both day 14 and day 21 | |||||||||||
| 47 |
IPI00129526 |
Endoplasmin |
766 |
1.40E-72 |
33 |
38 |
92703 |
4.74 |
TDDEVVQREEEAIQLDGLNASQIR;FAFQAEVNR;NKEIFLRELISNASDALDKIRLISLTDENALAGNEELTVK;NLLHVTDTGVGMTREELVKEVEEDEYKAFYK;ESDDPMAYIHFTAEGEVTFKSILFVPTSAPRGLFDEYGSKK;RVFITDDFHDMMPKYLNFVKGVVDSDDLPLNVSR;IADEKYNDTFWK;LGVIEDHSNR;FQSSHHSTDITSLDQYVER;QDKIYFMAGSSRKEAESSPFVEREATEKEFEPLLNWMK;LTESPCALVASQYGWSGNMER;DISTNYYASQKKTFEINPR;AYGDRIER |
1.54 |
Metabolic process |
| 48 |
IPI00123639 |
Calreticulin |
292 |
3.60E-25 |
5 |
16 |
48136 |
4.33 |
EQFLDGDAWTNR;HEQNIDCGGGYVK;IDNSQVESGSLEDDWDFLPPKKIKDPDAAKPEDWDER;GEWKPR |
1.66 |
Immune system process, |
| 49 |
IPI00131830 |
Serine protease inhibitor A3K |
175 |
1.80E-13 |
6 |
21 |
47021 |
5.05 |
ALYQTEAFTADFQQPTEAK;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;AVLDVAETGTEAAAATGVIGGIR; |
1000000 |
Enzyme regulator activity |
| 50 |
IPI00131830 |
Serine protease inhibitor A3K |
336 |
1.40E-29 |
9 |
27 |
47021 |
5.05 |
GKTMEEILEGLK;DLQILAEFHEK;ALYQTEAFTADFQQPTEAK;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;AVLDVAETGTEAAAATGVIGGIR |
12.57 |
Enzyme regulator activity |
| 51 |
IPI00131830 |
Serine protease inhibitor A3K |
316 |
1.40E-27 |
8 |
26 |
47021 |
5.05 |
DLQILAEFHEK;ALYQTEAFTADFQQPTEAK;ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLRK;FSIASNYR;AVLDVAETGTEAAAATGVIGGIR |
5.29 |
Enzyme regulator activity |
| 52 |
IPI00131830 |
Serine protease inhibitor A3K |
187 |
1.10E-14 |
5 |
16 |
47021 |
5.05 |
ISFDPQDTFESEFYLDEKR;HFRDEELSCSVLELK;MQQVEASLQPETLR;AVLDVAETGTEAAAATGVIGGIR |
1000000 |
Enzyme regulator activity |
| 53 |
IPI00131287 |
Isoform 1 of N-terminal EF-hand calcium-binding protein 2 |
374 |
2.30E-33 |
11 |
28 |
43870 |
5.18 |
APLVPDIPSADPGPGPAASRGGTAVILDIFR;KVYEGGSNVDQFVTR;YGGPTPPYIPNHK;TLSFDLQQRLSDEEGTNMHLQLVRQEMAVCPEQLSEFLDSLR;NCFHVAAVR |
1000000 |
Cell part and binding |
| 54 |
IPI00928020 |
Putative uncharacterized protein Otub1 |
331 |
4.50E-29 |
7 |
25 |
28190 |
5.15 |
IQQEIAVQNPLVSER;EYAEDDNIYQQK;YSYIRKTRPDGNCFYR;LLTSGYLQR;FFEHFIEGGR |
1.89 |
Metabolic process |
| 55 |
IPI00323571 |
Apolipoprotein E |
329 |
7.20E-29 |
14 |
39 |
35901 |
5.56 |
FWDYLR;ELEEQLGPVAEETR;LGADMEDLR;NEVHTMLGQSTEEIR;LSTHLR;LGPLVEQGR;TANLGAGAAQPLR;AQAFGDR;GRLEEVGNQAR;SKMEEQTQQIRLQAEIFQAR;GWFEPIVEDMHR |
1000000 |
Binding and antioxidant activity, |
| 56 | IPI00278230 | NFU1 iron-sulfur cluster scaffold homolog | 131 | 4.50E-09 | 5 | 17 | 28922 | 4.92 | FIPGKPVLETRTMDFPTPAAAFR;IRPTVQEDGGDVIYRGFEDGIVR | 1000000 | Organelle and organelle part |